Key result
Higher updated mean HbA1c linked to ~15% greater MI risk per 1% increase in T2D.
Why the study?
The risk of myocardial infarction by impaired glycemic control in a contemporary large cohort of patients with type 2 diabetes from diagnosis was evaluated to clarify associations of different HbA1c metrics with MI risk.
Do different HbA1c metrics predict the risk of myocardial infarction in patients with type 2 diabetes?
Cohort (n=101,799)
Do different HbA1c metrics predict the risk of myocardial infarction in patients with type 2 diabetes?
Hazard Ratio: 1.15 (95% CI 1.13–1.18)
Time-updated HbA1c variables are stronger predictors of myocardial infarction than baseline HbA1c in patients with type 2 diabetes, and recent cohorts show increased MI risk even at HbA1c <6.0%.
May refine MI risk prediction with time-updated HbA1c in T2D; hypothesis-generating, should not yet change practice.
OBJECTIVE: This study evaluated the risk of myocardial infarction (MI) by impaired glycemic control in a contemporary large cohort of patients with type 2 diabetes followed from diagnosis. RESEARCH DESIGN AND METHODS: Patients with type 2 diabetes diagnosed between 1995 and 2011 were retrieved from the Clinical Practice Research Datalink in the U.K., and followed from diagnosis until event of MI or end of study in 2013. Two subcohorts were defined: an early cohort with those diagnosed from 1997 to 2004 and a recent cohort with those diagnosed from 2004 to 2011. Association between each of three HbA1c metrics and MI was estimated using adjusted proportional hazards models. RESULTS: In the overall cohort (n = 101,799), the risk increase for MI per 1% (10 mmol/mol) increase in HbA(1c) was higher for updated latest and updated mean HbA(1c) of 1.11 (95% CI 1.09-1.13) and 1.15 (1.13-1.18) than for baseline HbA(1c) of 1.05 (1.03-1.06). In the early subcohort, the corresponding risk estimates were greater than those in the recent subcohort. When categorized, the updated latest variable showed an increased risk for HbA(1c) <6% (42 mmol/mol), relative category 6-7%, in the recent but not in the early subcohort, with hazard ratios of 1.23 (1.08-1.40) and 1.01 (0.84-1.22), respectively. CONCLUSIONS: The two time-updated HbA(1c) variables show a stronger relation with MI than baseline HbA(1c). The risk association between HbA(1c) and MI has decreased over time. In recently diagnosed patients with type 2 diabetes, an increased risk of MI exists at a current HbA(1c) of <6.0% (42 mmol/mol).
No takes yet. Share an insight, caveat, or question.
Olsson et al. (2015) conducted a cohort in Type 2 diabetes (n=101,799). Impaired glycemic control (HbA1c) vs. Lower HbA1c levels was evaluated on Myocardial infarction (HR 1.15, 95% CI 1.13-1.18). Time-updated mean HbA1c showed a strong association with myocardial infarction risk in type 2 diabetes, with a 1% increase in HbA1c increasing risk (HR 1.15; 95% CI 1.13-1.18).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: